Lawton, MI, United States of America

Fred L Ciske

This inventor holds 6 USPTO granted patents. Top assignees: Pharmacia & Upjohn Company, Pharmacia & Upjohn. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fred L Ciske. Retrieved from https://idiyas.com/inventor/fred-l-ciske

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Fred L Ciske: Innovator in Antiviral Agents

Introduction

Fred L Ciske is a notable inventor based in Lawton, MI (US), recognized for his contributions to the field of antiviral agents. With a total of six patents to his name, Ciske has made significant strides in developing compounds that target viruses, particularly those belonging to the herpes family.

Latest Patents

Among his latest patents, Ciske has developed "Heterocycle carboxamides as antiviral agents," which presents a compound useful in combating herpes viruses. Another significant patent is "4-Oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents," which also focuses on compounds effective against herpes family viruses. These innovations highlight his commitment to advancing antiviral research.

Career Highlights

Ciske has had a distinguished career, working with prominent companies such as Pharmacia & Upjohn Company and Pharmacia & Upjohn. His work in these organizations has allowed him to contribute to the development of important pharmaceutical products.

Collaborations

Throughout his career, Ciske has collaborated with notable colleagues, including Michael J Genin and Mark E Schnute. These partnerships have likely enriched his research and development efforts in the field of antiviral agents.

Conclusion

Fred L Ciske's innovative work in developing antiviral agents has made a significant impact in the pharmaceutical industry. His patents and collaborations reflect his dedication to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…